CrushSCI.com
Journal Selection & Manuscript Polishing Services
HISTOPATHOLOGY journal cover Medicine
Back to journal directory

Review Cycle Records

HISTOPATHOLOGY

Wiley SCIE Non-OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q1
109.3Average days
82Median days
7Fastest days
366Longest days
2512025 publications

Paper Review Records

All Paper Review Records

19 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

7 days

Professor Mary Leader: an obituary

AuthorsElaine W. Kay; Michael A. Farrell

Affiliations1. Royal College of Surgeons in Ireland, Beaumont Hospital Dublin Ireland; 2. Beaumont Hospital Dublin 9 Ireland

Source PDF DOI Publisher page
35 days

Does renal haemangioblastoma exist? Evidence for inclusion within the MTOR ‐associated renal cell carcinoma with fibromyomatous stroma spectrum

AuthorsSean R. Williamson; Reza Alaghehbandan

Affiliations1. Department of Pathology, Diagnostics Institute Cleveland Clinic Foundation Cleveland OH USA

Source PDF DOI Publisher page
71 days

A novel classification of testicular sex cord‐stromal tumours from the Testicular Sex Cord‐Stromal Tumour ( TESST ) group: a collaboration of the Genitourinary Pathology Society ( GUPS ) and the International Society of Urological Pathology ( ISUP )

AuthorsAndres M. Acosta; Felix Bremmer; John C. Cheville; Maurizio Colecchia; Eva Comperat; Kristine Cornejo; Dilek E. Baydar; Anthony J. Gill; Maria del Pilar Gonzalez‐Peramato; Sounak Gupta; Michelle S. Hirsch; Muhammad T. Idrees; Chia‐Sui Kao; Fiona MacLean; Andres Matoso; Rohit Mehra; Santosh Menon; Kvetoslava Michalova; Sambit K. Mohanty; Miguel Reyes‐Mugica; Maria Rosaria Raspollini; Ankur R. Sangoi; Lynette M. Sholl; Stephanie Siegmund; Satish K. Tickoo; Toyonori Tsuzuki; Thomas M. Ulbright; Sean R. Williamson; Asli Yilmaz; Daniel M. Berney

Affiliations1. Department of Pathology Indiana University Indianapolis IN USA; 2. Institute of Pathology University Medical Center Göttingen Göttingen Germany; 3. Department of Pathology Mayo Clinic Rochester MN USA; 4. Department of Pathology Universita Vita Salute San Raffaele Milan Italy; 5. Department of Pathology Medical University Vienna Vienna Austria; 6. Department of Pathology Koc University School of Medicine Istanbul Turkey; 7. Department of Pathology, Sydney Medical School University of Sydney Sydney NSW Australia; 8. Department of Pathology University Hospital La Paz, Universidad Autónoma de Madrid Madrid Spain; 9. Department of Pathology MassGeneralBrigham/Harvard Medical School Boston MA USA; 10. Department of Pathology and Laboratory Medicine, Diagnostics Institute Cleveland Clinic Cleveland OH USA; 11. Department of Pathology, Douglass Hanly Moir Pathology Sonic Healthcare Sydney NSW Australia; 12. Department of Pathology Johns Hopkins University Baltimore MD USA; 13. Department of Pathology University of Michigan Ann Arbor MI USA; 14. Department of Pathology Tata Memorial Centre Mumbai India; 15. Department of Pathology Charles University, Faculty of Medicine in Plzen, Biopticka Laborator, Ltd Plzen Czech Republic; 16. Department of Pathology CORE Diagnostics Gurgaon Haryana India; 17. Department of Pathology University of Miami Miller School of Medicine Miami FL USA; 18. Histopathology and Molecular Diagnostics University Hospital Careggi and University of Florence Florence Italy; 19. Department of Pathology Stanford University Stanford CA USA; 20. Department of Pathology Memorial Sloan‐Kettering Cancer Center New York NY USA; 21. Department of Surgical Pathology Aichi Medical University Nagakute Japan; 22. Department of Diagnostic and Molecular Pathology Alberta Precision Labs and University of Calgary Calgary AB Canada; 23. Centre of Cancer Biomarkers and Biotherapeutics, Barts Cancer Institute, Charterhouse Square Queen Mary University of London London UK

Source PDF DOI Publisher page
133 days

High interobserver variability exists in grading appendiceal goblet cell adenocarcinoma using World Health Organization 5th edition criteria

AuthorsLidiane Vieira Marins; Raphiel Murden; Joseph Misdraji; Michelle D. Reid; Laura Tang; Sarah Umetsu; Hanlin L. Wang; Kwun Wah Wen; Rhonda K. Yantiss; Azhar Nizam; David A. Gutman; Raul S. Gonzalez

Affiliations1. Laboratório de Patologia Rede D'Or and Instituto D'Or de Pesquisa e Ensino São Paulo SP Brazil; 2. Department of Biostatistics, Rollins School of Public Health Emory University Atlanta GA USA; 3. Department of Pathology Yale University New Haven CT USA; 4. Department of Pathology and Laboratory Medicine Emory University Hospital Atlanta GA USA; 5. Department of Pathology Memorial Sloan Kettering Cancer Center New York NY USA; 6. Department of Pathology University of California San Francisco San Francisco CA, FL USA; 7. Department of Pathology University of California Los Angeles Los Angeles California USA; 8. Department of Pathology and Laboratory Medicine University of Miami Miami FL USA; 9. Department of Biomedical Informatics Emory University School of Medicine Atlanta GA USA

Source PDF DOI Publisher page
82 days

Aberrant p53 overexpression in benign colon biopsies may predict dysplasia risk in patients with primary sclerosing cholangitis and inflammatory bowel disease

AuthorsJonathan D Louie; Gregory Y Lauwers; Won‐Tak Choi

Affiliations1. Department of Pathology University of California at San Francisco San Francisco California USA; 2. Department of Anatomic Pathology H. Lee Moffitt Cancer Center and Research Institute Tampa Florida USA

Source PDF DOI Publisher page
86 days

Diagnostic impact and reproducibility of p53 immunohistochemistry in Barrett's oesophagus: results of the Dutch Esophageal Pathology Panel ( DEPP )

AuthorsYlva A. Weeda; Sarah M. Issa; Hans Halfwerk; Michel Botros; Onno J. de Boer; Lodewijk A. Brosens; Michail Doukas; Gursah Kats‐Ugurlu; Fiebo ten Kate; Jaap van der Laan; Ineke van Lijnschoten; Ariadne H. A. G. Ooms; Lindsey Oudijk; Rachel S. van der Post; Mihaela G. Raicu; Bert Timmer; Myrtle J. van der Wel; Sybren L. Meijer

Affiliations1. Department of Pathology Amsterdam University Medical Center at the University of Amsterdam Amsterdam the Netherlands; 2. Cancer Center Amsterdam, Biomarkers Amsterdam the Netherlands; 3. Department of Biomedical Engineering and Physics Amsterdam University Medical Center at the University of Amsterdam Amsterdam the Netherlands; 4. Department of Pathology University Medical Center Utrecht, Utrecht University Utrecht the Netherlands; 5. Department of Pathology Erasmus University Medical Center Rotterdam the Netherlands; 6. Department of Pathology and Medical Biology University Medical Center Groningen Groningen the Netherlands; 7. Department of Pathology Isala Klinieken Zwolle the Netherlands; 8. Department of Pathology HAGA Hospital The Hague the Netherlands; 9. Catharina Hospital, PAMM Eindhoven the Netherlands; 10. Pathan BV Rotterdam the Netherlands; 11. Department of Pathology Maasstad Hospital Rotterdam the Netherlands; 12. Department of Pathology Radboud University Medical Center Nijmegen the Netherlands; 13. Department of Pathology St. Antonius Hospital Nieuwegein the Netherlands

Source PDF DOI Publisher page
34 days

Clinicopathological and molecular features of uterine smooth muscle tumours in patients with Li‐Fraumeni syndrome

AuthorsLawrence H Lin; Igor Odintsov; Emily A Towery; Bradley J Quade; Marisa R Nucci; Zehra Ordulu; David L Kolin

Affiliations1. Department of Pathology, Brigham and Women's Hospital, Mass General Brigham Enterprise Harvard Medical School Boston Massachusetts USA; 2. Department of Pathology, Massachusetts General Hospital, Mass General Brigham Enterprise Harvard Medical School Boston Massachusetts USA; 3. Department of Pathology Beth Israel Deaconess Medical Center, Harvard Medical School Boston Massachusetts USA

Source PDF DOI Publisher page
55 days

Effects of short‐course preoperative endocrine therapy on tumour morphology and immunohistochemical profile in oestrogen receptor‐positive, HER2 ‐negative breast cancer

AuthorsClaudia Grosse; Alexandra Grosse; Petar Noack; Caroline Ines Preuss; Heike Kathleen Schwarz; Bruno Schneeweiss; Thomas Gitter; Peter Schrenk; Rupert Langer

Affiliations1. Department of Clinical Pathology and Molecular Pathology Johannes Kepler University Linz, Kepler University Hospital GmbH Linz Austria; 2. Pathology Medica Enge AG Zurich Switzerland; 3. Department of Gynaecology, Obstetrics and Gynaecological Endocrinology Johannes Kepler University Linz, Kepler University Hospital GmbH Linz Austria; 4. Department of Haematology and Oncology Johannes Kepler University Linz, Kepler University Hospital GmbH Linz Austria; 5. Central Radiology Institute Johannes Kepler University Linz, Kepler University Hospital GmbH Linz Austria; 6. Department of General and Visceral Surgery Johannes Kepler University Linz, Kepler University Hospital GmbH Linz Austria

Source PDF DOI Publisher page
272 days

Correlative assessment of p53 immunostaining patterns and TP53 mutation status by next‐generation sequencing in lung adenocarcinoma ( LUAD )

AuthorsYingying Zhang; Ke Zheng; Yuan Tang; Ke Yang; Zihang Chen; Yuli Li; Yajing Zhang; Guiping Zhang; Li Qiu; Ran Peng; Xiaoyu Liu; Lili Jiang

Affiliations1. Department of Pathology, West China Hospital Sichuan University Chengdu P.R. China

Source PDF DOI Publisher page
128 days

Pathological assessment of tumour beds in breast excisions post‐neoadjuvant therapy: a retrospective cohort study

AuthorsAngela Cheng; Penelope Barnes; Daniel Rayson; Christopher Liwski; Gillian Bethune

Affiliations1. Department of Pathology Dalhousie University Halifax Nova Scotia Canada; 2. Division of Medical Oncology, Department of Medicine Dalhousie University Halifax Nova Scotia Canada

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.